Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference44 articles.
1. Lee JH, Sung T-E, Kim E, Shin K. Evaluating determinant priority of license fee in biotech industry. J Open Innov: Technol, Mark Complex. 2018;4(3):30.
2. DiMasi J, Hermann J, Twyman K, Kondru R, Stergiopoulos S, Getz K, et al. A tool for predicting regulatory approval after phase II testing of new oncology compounds. Clin Pharmacol Ther. 2015;98(5):506–13.
3. Kim J. Development duration analysis on the new molecular entity pipelines of pharmaceutical firms in Korea. Seoul: Sungkyunkwan University; 2018.
4. Thomas D, Micklus A, LaFever S. Clinical development success rates and contributing factors 2011–2020. 2021.
5. Moon H. Basic analysis of the pharmaceutical industry. 2011.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献